Intuitive Surgical INC Form 4 insider transactions

Intuitive Surgical's EVP & CFO, Jamie Samath, reported the vesting and conversion of Restricted and Performance Stock Units into common stock, alongside related tax withholdings.

Intuitive Surgical's EVP & Chief Legal and Compliance Officer, Gary Loeb, reported the vesting of performance stock units and subsequent tax-related share withholding.

Intuitive Surgical's EVP & Chief Commercial and Marketing Officer, Henry L. Charlton, converted restricted and performance stock units into common stock, with shares withheld for tax obligations.

Intuitive Surgical CEO David J. Rosa reported the vesting of restricted and performance stock units, along with associated tax withholdings, on February 28, 2026.

Intuitive Surgical's SVP Mark Brosius reported the vesting of restricted and performance stock units, alongside associated tax withholdings.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, reported sales of common stock and the vesting of Restricted and Performance Stock Units under a pre-arranged trading plan.

Intuitive Surgical's SVP of Human Resources, Patricia Wadors, sold common stock following the vesting of restricted stock units, executed under a pre-arranged 10b5-1 trading plan.

An Intuitive Surgical executive reported the vesting and acquisition of restricted stock units and performance stock units, alongside related tax withholdings.

Intuitive Surgical's EVP & Chief Commercial and Marketing Officer, Henry L. Charlton, reported multiple equity transactions related to RSU and PSU vesting.

Intuitive Surgical's EVP & CFO, Jamie Samath, reported multiple transactions involving common stock, Restricted Stock Units (RSUs), and Performance Stock Units (PSUs) on February 26, 2026.

Intuitive Surgical's EVP & Chief Legal and Compliance Officer, Gary Loeb, reported routine equity transactions including RSU vesting, PSU achievement, and tax-related share dispositions.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, reported the vesting of restricted and performance stock units, leading to the acquisition and subsequent tax-related disposition of common stock.

Intuitive Surgical's VP Corporate Controller, Fredrik Widman, reported the conversion of Restricted Stock Units into common stock and subsequent tax-related dispositions.

Intuitive Surgical CEO David J. Rosa reported the vesting and exercise of restricted stock units and the achievement of performance criteria for performance stock units, alongside tax-related share dispositions.

Intuitive Surgical Director Gary S. Guthart reported future vesting and tax-related disposition of company stock and performance units under a Rule 10b5-1 plan.

Intuitive Surgical's SVP & Chief Manufacturing and Supply Chain, Mark Brosius, reported the vesting and acquisition of common stock and restricted/performance stock units, alongside tax-related dispositions.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, reported a series of stock acquisitions and dispositions, including RSU vesting and option exercises, executed under a 10b5-1 trading plan.

Intuitive Surgical's VP Corporate Controller, Fredrik Widman, reported the acquisition of common stock from RSU vesting and subsequent sales for tax withholding and under a 10b5-1 plan.

Intuitive Surgical Director Gary S. Guthart reported the vesting of restricted stock units and a subsequent tax-related sale of common stock.

Intuitive Surgical's EVP & Chief Legal Officer, Gary Loeb, reported the vesting of restricted stock units and subsequent sale of shares for tax purposes.

Intuitive Surgical SVP Iman Jeddi reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Intuitive Surgical's EVP & CFO, Jamie Samath, acquired common stock through RSU vesting and simultaneously sold shares to cover tax obligations.

Intuitive Surgical's EVP & Chief Commercial and Marketing Officer, Henry L. Charlton, vested 1,077 restricted stock units and sold 492 shares to cover tax obligations.

Intuitive Surgical's SVP & Chief Manufacturing and Supply Chain, Mark Brosius, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Intuitive Surgical Director Keith R. Leonard reported a transfer of 369 common shares pursuant to a divorce decree.

Intuitive Surgical's SVP & Chief Manufacturing and Supply Chain, Mark Brosius, acquired 8,287 performance stock units after achieving set metrics.

Intuitive Surgical's EVP & Chief Legal and Compliance Officer, Gary Loeb, has achieved performance criteria for two tranches of Performance Stock Units, totaling 4,641 shares.

Intuitive Surgical CEO David J. Rosa has achieved performance metrics for multiple tranches of Performance Stock Units, leading to future vesting.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, exercised stock options and sold shares, while also acquiring performance stock units.

Intuitive Surgical Director Gary S. Guthart reported the acquisition of performance stock units following the achievement of performance metrics.